Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 4/15/01 → 12/31/08 |
Financiación
- Merck and Company Inc: 111.151,00 US$
Protocol 008-01 Study to Evaluate the Safety, Tolerability & Immunogenicity of the HIV-1 Gag DNA Vaccine Formulated with PBS or with Aluminum Phosphage Followed by AD5 HIV-1 Gag Vaccine in a Prime Boost Regimen
- Greenberg, Richard (PI)
- Pomeroy, Claire (CoI)